Table 4. Baseline characteristics in the validation cohort.
| Risk factor | Men | Women | ||
|---|---|---|---|---|
| Total (%) (n = 500,046) | Event (%) (n = 711) | Total (%) (n = 627,629) | Event (%) (n = 576) | |
| Height (cm) in men | ||||
| ≤165 | 178,435 (35.68) | 356 (50.07) | ||
| >165, ≤168 | 95,627 (19.12) | 136 (19.13) | ||
| >168, ≤172 | 119,951 (23.99) | 137 (19.27) | ||
| >172 | 106,033 (21.20) | 82 (11.53) | ||
| Height (cm) in women | ||||
| ≤151 | 181,483 (28.92) | 293 (50.87) | ||
| >151, ≤155 | 164,080 (26.14) | 148 (25.69) | ||
| >155, ≤158 | 121,705 (19.39) | 74 (12.85) | ||
| >158 | 160,361 (25.55) | 61 (10.59) | ||
| BMI (kg/m2) | ||||
| <18.5 | 15,641 (3.13) | 40 (5.63) | 25,726 (4.10) | 15 (2.60) |
| 18.5–22.9 | 198,824 (39.76) | 319 (44.87) | 274,568 (43.75) | 203 (35.24) |
| 23.0–24.9 | 132,473 (26.49) | 174 (24.47) | 148,049 (23.59) | 144 (25.00) |
| ≥25.0 | 153,108 (30.62) | 178 (25.04) | 179,286 (28.57) | 214 (37.15) |
| Blood glucose (mg/dL) | ||||
| <140 | 474,825 (94.96) | 633 (89.03) | 605,146 (96.42) | 527 (91.49) |
| ≥140 | 25,221 (5.04) | 78 (10.97) | 22,483 (3.58) | 49 (8.51) |
| Urine glucose | ||||
| Negative | 476,949 (95.38) | 649 (91.28) | 613,231 (97.71) | 544 (94.44) |
| Positive | 23,097 (4.62) | 62 (8.72) | 14,398 (2.29) | 32 (5.56) |
| Smoking | ||||
| Never | 160,044 (32.01) | 231 (32.49) | 599,007 (95.44) | 510 (88.54) |
| Past | 61,255 (12.25) | 92 (12.94) | 6,480 (1.03) | 9 (1.56) |
| Current | 22,142 (3.53) | 57 (9.90) | ||
| <0.5 pack/day | 49,696 (9.94) | 87 (12.24) | ||
| 0.5–0.9 pack/day | 147,971 (29.59) | 196 (27.57) | ||
| ≥1 pack/day | 81,080 (16.21) | 105 (14.77) | ||
| Age at smoking initiation | ||||
| Never | 160,044 (32.01) | 231 (32.49) | ||
| Past | 61,255 (12.25) | 92 (12.94) | ||
| Age≥25 | 179,459 (35.89) | 329 (46.27) | ||
| Age<25 | 99,288 (19.86) | 59 (8.30) | ||
| Drinking habit | ||||
| ≤2–3 times/month | 588,165 (93.71) | 545 (94.62) | ||
| ≥1–2 times/week | 39,646 (6.29) | 31 (5.38) | ||